Josephs Paul — SEC Form 4 filings

SEC reporting owner CIK 2022547. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-22 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Chief Executive Officer, Director61 leg · 17,000 sh · $97,58010

Form 4 filings — Josephs Paul

FiledFormIssuerReported transactionsSource
2026-05-214LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Tax withholding (F): 40,413 @ $4.57EDGAR
2025-07-104LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Option exercise (M): 150,000 · Tax withholding (F): 54,857 @ $8.19 · Option exercise (M): 150,000 (derivative)EDGAR
2025-05-224LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Tax withholding (F): 21,532 @ $6.63EDGAR
2025-01-084LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Purchase (P): 17,000 @ $5.74EDGAR
2024-12-104LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Grant/award (A): 38,461 @ $0 · Tax withholding (F): 11,769 @ $7.15EDGAR
2024-05-224LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Grant/award (A): 525,000 · Tax withholding (F): 8,975 · Grant/award (A): 1,500,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2022547 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →